Scarica l'app Stockscreener
39.00
3.37%
1.27
Dopo l'orario di chiusura:
39.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Precedente Chiudi:
$37.73
Aprire:
$38.37
Volume 24 ore:
579.26K
Relative Volume:
0.64
Capitalizzazione di mercato:
$3.94B
Reddito:
-
Utile/perdita netta:
$-804.34M
Rapporto P/E:
-4.1445
EPS:
-9.41
Flusso di cassa netto:
$-531.06M
1 W Prestazione:
-4.20%
1M Prestazione:
+9.00%
6M Prestazione:
+1.48%
1 anno Prestazione:
-10.98%
Intervallo 1D:
$38.27
$39.60
Intervallo di 1 settimana:
$37.53
$41.00
Portata 52W:
$26.80
$62.21
Biohaven Ltd Stock (BHVN) Company Profile
Nome
Biohaven Ltd
Settore
Industria
Telefono
203-404-0410
Indirizzo
215 CHURCH STREET, NEW HAVEN, CT
Confronta BHVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
39.00 | 3.94B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-16 | Iniziato | Jefferies | Buy |
| 2024-09-04 | Iniziato | Bernstein | Outperform |
| 2024-07-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2023-12-22 | Iniziato | H.C. Wainwright | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-01-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-04 | Iniziato | JP Morgan | Overweight |
| 2022-12-02 | Iniziato | BTIG Research | Buy |
| 2022-10-26 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Iniziato | Piper Sandler | Overweight |
| 2022-08-19 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-05-11 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Downgrade | UBS | Buy → Neutral |
| 2021-08-03 | Reiterato | Canaccord Genuity | Buy |
| 2021-03-11 | Iniziato | UBS | Buy |
| 2020-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-17 | Iniziato | Cowen | Outperform |
| 2020-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2019-11-22 | Iniziato | Wedbush | Outperform |
| 2019-06-25 | Reiterato | Canaccord Genuity | Buy |
| 2019-05-06 | Iniziato | Goldman | Buy |
| 2019-04-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Reiterato | Needham | Buy |
| 2018-07-03 | Reiterato | Needham | Buy |
| 2018-07-02 | Reiterato | Needham | Buy |
| 2018-04-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Reiterato | Canaccord Genuity | Buy |
| 2017-12-15 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-03 | Reiterato | Needham | Buy |
Mostra tutto
Biohaven Ltd Borsa (BHVN) Ultime notizie
Nebraska Joins in Settling Kickback Allegations against Biohaven Pharmaceutical Holding Company Ltd. - Rural Radio Network
Nebraska joins in settling kickback allegations against Biohaven - norfolkneradio.com
Pfizer to pay nearly $60M over kickbacks for migraine drug developed by New Haven-based Biohaven - Hartford Business Journal
Nebraska joins in settling kickback allegations against Biohaven Pharmaceutical Holding Company Ltd. - News Channel Nebraska
Nebraska joins multi-state settlement against Biohaven Pharmaceutical for kickback allegations - News Channel Nebraska
Pfizer settles Biohaven kickback claims case for $59.7m - Yahoo Finance
Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force - Benzinga
Pfizer settles Biohaven kickback case with DOJ for $60M - MSN
Pfizer settles Biohaven kickback case with DOJ for $60M (PFE:NYSE) - Seeking Alpha
When (BHVN) Moves Investors should Listen - Stock Traders Daily
Cantor Fitzgerald Forecasts Biohaven FY2025 Earnings - MarketBeat
Biohaven Ltd. (NYSE:BHVN) Stock Holdings Raised by ARS Investment Partners LLC - MarketBeat
Biohaven Ltd. (NYSE:BHVN) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Insider Stock Buying Reaches US$23.8m On Biohaven - Simply Wall St
Biohaven’s stock surges as treatment slows progress of neurological disorder - MSN
Biohaven (NYSE:BHVN) Trading Down 6.4%Here's What Happened - MarketBeat
Biohaven Refines Epilepsy Trial Design With Patient-Centric Focus - Clinical Leader
Motor Neuron Disease Clinical and Non-Clinical Studies, Key - openPR
Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals - News & Insights
Biohaven (NYSE:BHVN) Stock Price Down 6.4%Should You Sell? - MarketBeat
Why Biohaven Ltd. Stocks Are Rising Now - TipRanks
What's Going On With Merus Stock Monday?Biohaven (NYSE:BHVN), Merus (NASDAQ:MRUS) - Benzinga
Biohaven & Merus Team Up to Develop Novel Bispecific ADC Therapies - Contract Pharma
Biohaven Showcases TRAP Degraders at J.P. Morgan Conference - TipRanks
Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generatio - PR Newswire
Merus and Biohaven Partner to Develop Next-Generation Cancer-Fighting ADC Therapies - StockTitan
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs - The Manila Times
Biohaven (NYSE:BHVN) Shares Gap DownHere's What Happened - MarketBeat
Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
JPMorgan Chase & Co. Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares - Yahoo Finance
Long Term Trading Analysis for (BHVN) - Stock Traders Daily
Biohaven Announces Conference Call to Discuss Topline Pivotal St - GuruFocus.com
Biohaven Stock Surges After Director Acquires Shares Worth Over $1M: Retail Sentiment Turns Bullish - MSN
Biohaven (NYSE:BHVN) Shares Gap Up on Insider Buying Activity - MarketBeat
John W. Childs Buys 29,000 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - MarketBeat
Biohaven Ltd. Stocks Surge Amid Positive Developments - TipRanks
Biohaven director John Childs acquires shares worth $1.04 million By Investing.com - Investing.com Nigeria
Biohaven director John Childs acquires shares worth $1.04 million - Investing.com
Biohaven Ltd. (NYSE:BHVN) Receives $63.00 Average Price Target from Brokerages - MarketBeat
Biohaven Enters Oversold Territory (BHVN) - Nasdaq
How To Trade (BHVN) - Stock Traders Daily
Biohaven Ltd Azioni (BHVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.49%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):